Cellular circadian period

Biomarker

2 papers5 findings

  • Humans2

Associations

5

p-Tau217

upin humans1

1 study
  1. Cellular circadian period is associated with p-Tau217 in humans.

    “A longer intrinsic circadian period was selectively associated with higher pTau-217, NfL, and GFAP levels and medial temporal atrophy”

    Humansin older adults with cognitive complaintsn = 135

    Cellular circadian period and its deviation associate with Alzheimer's pathology and brain aging in cognitively impaired older adults

    Proceedings of the National Academy of Sciences of the United States of America2 Mar 2026

More on p-Tau217

Clinical decline

upin humans1HR 4.41

1 study
  1. Cellular circadian period predicts clinical decline in humans (HR = 4.41, 95% CI: 1.52 to 12.83).

    “Both longer period (HR = 4.41, 95% CI: 1.52 to 12.83) and greater Δ-period (HR = 2.65, 95% CI: 1.03 to 6.86) independently predicted faster clinical decline.”

    Humansin older adults with cognitive complaintsn = 135

    Cellular circadian period and its deviation associate with Alzheimer's pathology and brain aging in cognitively impaired older adults

    Proceedings of the National Academy of Sciences of the United States of America2 Mar 2026

NfL

upin humans1

1 study
  1. Cellular circadian period is associated with NfL in humans (p <0.001).

    “neural injury and degeneration (plasma NfL, p <0.001, large effect size; MRI Schelten's scale, p = 0.033, small effect size)”

    Humansolder adults with cognitive complaintsn = 135

    Associations of ex‐vivo cellular circadian period with aging, tau, neurodegeneration, inflammation and clinical progression in older adults with cognitive impairment: Findings from BICWALZS cohort

    AAIC 2025 abstract23 Dec 2025

More on NfL

pTau-217

upin humans1

1 study
  1. Cellular circadian period is associated with pTau-217 in humans (p = 0.012).

    “The cellular circadian period was significantly associated with tau proteinopathy (plasma pTau‐217, p = 0.012, small effect size)”

    Humansolder adults with cognitive complaintsn = 135

    Associations of ex‐vivo cellular circadian period with aging, tau, neurodegeneration, inflammation and clinical progression in older adults with cognitive impairment: Findings from BICWALZS cohort

    AAIC 2025 abstract23 Dec 2025

More on pTau-217

Clinical progression

upin humans1HR 3.59

1 study
  1. Cellular circadian period raises the risk of clinical progression in humans (HR=3.59, p = 0.01).

    “Survival analysis showed that longer cellular circadian period were associated with faster clinical progression (HR=3.59, p = 0.01).”

    Humansolder adults with cognitive complaintsn = 135

    Associations of ex‐vivo cellular circadian period with aging, tau, neurodegeneration, inflammation and clinical progression in older adults with cognitive impairment: Findings from BICWALZS cohort

    AAIC 2025 abstract23 Dec 2025

Latest

Nov 2025: 0Dec 2025: 1Jan 2026: 0Feb 2026: 0Mar 2026: 1Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 02 in 12 months